Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366248 · ClinicalTrials.gov registry record
Integrative Oncology Outcomes Study in Breast Cancer
A clinical trial, sponsored by Bastyr University.
- Completed
- Registry status
- 750
- Enrollment target
NCT01366248 is a clinical trial that has completed, run by Bastyr University. The registered enrollment target is 750 participants.
The verdict
NCT01366248 has completed, sponsored by Bastyr University.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings. Hypothesis: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment on their own.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2010-08 |
| Est. Completion | 2017-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366248
The ClinicalTrials.gov registry entry for NCT01366248 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01366248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366248 about?
NCT01366248 is a clinical study titled "Integrative Oncology Outcomes Study in Breast Cancer". This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings. Hypothesis: IO services impro...
What is the current status of trial NCT01366248?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2010-08. Estimated completion is 2017-12-31.
Who is sponsoring clinical trial NCT01366248?
This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.